Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Chau

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Cancer|June 20, 2020
Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancerGlenn J Hanna, Jeffrey P Guenette, Nicole G Chau, et al.
Cancer|August 11, 2016
Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neckNicole G Chau, Shelley Hurwitz, Chelsey M Mitchell, et al.
The American Journal of Surgical Pathology|September 16, 2017
Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic CarcinomaDipti P Sajed, William C Faquin, Chris Carey, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2019
A Phase 1 Study of Afatinib in Combination with Postoperative Radiation Therapy with and Without Weekly Docetaxel in Intermediate- and High-Risk Patients with Resected Squamous Cell Carcinoma of the Head and NeckDanielle N Margalit, Robert I Haddad, Roy B Tishler, et al.
Oral Oncology|March 30, 2017
Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neckGlenn J Hanna, Hongye Liu, Robert E Jones, et al.
The American Journal of Surgical Pathology|August 30, 2022
NUTM1 -rearranged Carcinoma of the Thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 FusionsJustine A Barletta, Steven D Gilday, Michelle Afkhami, et al.
International Journal of Radiation Oncology, Biology, Physics|July 2, 2018
Evaluating the PD-1 Axis and Immune Effector Cell Infiltration in Oropharyngeal Squamous Cell CarcinomaJonathan D Schoenfeld, Evisa Gjini, Scott J Rodig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2016
Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell CarcinomaNicole G Chau, Yvonne Y Li, Vickie Y Jo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II StudyGlenn J Hanna, Naifa L Busaidy, Nicole G Chau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2022
Report of the First International Symposium on NUT CarcinomaChristopher A French, Michael L Cheng, Glenn J Hanna, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Cancer|June 20, 2020
Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancerGlenn J Hanna, Jeffrey P Guenette, Nicole G Chau, et al.
Cancer|August 11, 2016
Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neckNicole G Chau, Shelley Hurwitz, Chelsey M Mitchell, et al.
The American Journal of Surgical Pathology|September 16, 2017
Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic CarcinomaDipti P Sajed, William C Faquin, Chris Carey, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2019
A Phase 1 Study of Afatinib in Combination with Postoperative Radiation Therapy with and Without Weekly Docetaxel in Intermediate- and High-Risk Patients with Resected Squamous Cell Carcinoma of the Head and NeckDanielle N Margalit, Robert I Haddad, Roy B Tishler, et al.
Oral Oncology|March 30, 2017
Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neckGlenn J Hanna, Hongye Liu, Robert E Jones, et al.
The American Journal of Surgical Pathology|August 30, 2022
NUTM1 -rearranged Carcinoma of the Thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 FusionsJustine A Barletta, Steven D Gilday, Michelle Afkhami, et al.
International Journal of Radiation Oncology, Biology, Physics|July 2, 2018
Evaluating the PD-1 Axis and Immune Effector Cell Infiltration in Oropharyngeal Squamous Cell CarcinomaJonathan D Schoenfeld, Evisa Gjini, Scott J Rodig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2016
Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell CarcinomaNicole G Chau, Yvonne Y Li, Vickie Y Jo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II StudyGlenn J Hanna, Naifa L Busaidy, Nicole G Chau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2022
Report of the First International Symposium on NUT CarcinomaChristopher A French, Michael L Cheng, Glenn J Hanna, et al.
Pageof 7